MetLife, 5.875% Senior Notes due 11/21/2033 (MLG)

Revenue

$18.88B

Quarterly · Period ending: · USD

MLG logo

MLG Revenue

Latest reported$18.88B
MLG Quarterly Revenue ($250.00M → $18.88B)
High-resolution chart · PNG

MLG revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

MetLife, 5.875% Senior Notes due 11/21/2033 Revenue — Quarterly (USD)
Period endingRevenue (USD)
18,877,000,000
19,074,000,000
23,814,000,000
16,881,000,000
17,176,000,000
18,263,000,000
18,440,000,000
18,298,000,000
17,491,000,000
15,902,000,000
19,028,000,000
15,866,000,000
16,623,000,000
15,388,000,000
16,316,000,000
22,283,000,000
15,473,000,000
15,405,000,000
20,089,000,000
16,905,000,000
19,586,000,000
15,562,000,000
19,418,000,000
16,015,000,000
14,099,000,000
18,310,000,000
17,143,000,000
18,678,000,000
17,497,000,000
16,302,000,000
15,662,000,000
16,289,000,000
21,185,000,000
14,805,000,000
15,993,000,000
16,171,000,000
15,333,000,000
14,964,000,000
12,076,000,000
15,573,000,000
15,244,000,000
18,433,000,000
17,044,000,000
18,031,000,000
16,166,000,000
18,710,000,000
19,119,000,000
18,846,000,000
18,266,000,000
17,085,000,000
18,458,000,000
16,337,000,000
15,721,000,000
17,683,000,000
17,333,000,000
14,635,000,000
19,557,000,000
17,188,000,000
16,745,000,000
21,871,000,000
18,422,000,000
17,089,000,000
12,837,000,000
12,338,000,000
14,138,000,000
13,100,000,000
12,341,000,000
10,238,000,000
8,265,000,000
10,214,000,000
13,885,000,000
13,351,000,000
12,049,000,000
11,624,000,000
13,821,000,000
11,678,000,000
13,217,000,000
12,912,000,000
12,893,000,000
12,528,000,000
11,351,000,000
11,532,000,000
11,546,000,000
11,988,000,000
10,955,000,000
10,257,000,000
10,053,000,000
9,972,000,000
9,471,000,000
9,417,000,000
9,746,000,000
8,721,000,000
8,863,000,000
8,362,000,000
8,801,000,000
8,124,000,000
8,201,000,000
7,975,000,000
8,176,000,000
7,817,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.